Navigation Links
ThermoGenesis Announces Filing of 510(k) Application for MarrowXpress
Date:6/4/2008

DEVICE DESIGNED TO PROVIDE POINT-OF-CARE BONE MARROW PROCESSING

RANCHO CORDOVA, Calif., June 4 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, today announced that it has submitted a 510(k) pre-market notification application to the FDA requesting regulatory clearance for its MarrowXpress(TM) (MXP(TM)), a device designed for the processing of bone marrow in a laboratory setting.

The device is a derivative of the Company's approved AutoXpress(TM) (AXP(TM)) Platform that is used to volume reduce and collect stem cells from umbilical cord blood.

"This is an important milestone in the Company's product diversification and growth strategy. We are hopeful that the regulatory process will be facilitated because the MXP is based on a currently approved device," said Dr. William Osgood, Chief Executive Officer.

Osgood said the Company expects to receive a CE Mark for the MXP this month, which would enable the Company to begin commercial marketing of the device in Europe.

"The use of adult stem cells to treat a variety of diseases and injuries is very promising. There are a number of clinical trials already underway, and in several countries it is a practice of medicine for indications such as critical limb ischemia, coronary artery disease and orthopedic conditions. We have had very encouraging discussions with leading research centers in both the U.S. and Europe regarding the potential use of the MXP in ongoing clinical trials and look forward to getting this device into the clinical setting. We believe this could ultimately represent a multi-billion dollar market opportunity for the Company," he added
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
2. ThermoGenesis Corp. Reports First Quarter 2008 Results
3. Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... an emotional rollercoaster, study finds , ... the fear factor meets the jubilant sports fan. ,...lly those who root for the winning team -- enjoy t...ed match and victory was in doubt, producing feeli...his Thanksgiving weekend as you,re glued to the TV...
(Date:11/26/2009)...ch Triangle Dental (RTDental), a leading dental gr...unced the expansion of its services to include LUM...acmillan. , Durham, NC... announce that Dr. Doug Macmillan, an experienced ...nal advanced training seminar. RTDental’s a...
(Date:11/25/2009)...swire-USNewswire/--WhenmostpeopleheartheacronymTMJ...vepatientsthehelptheyneed.TMJstandsfortheTemporal-...cts/connectswithyourskull(temporalbone). ,, The...ainwithchewing,clickingorpoppingofthejaw.Butmanyot...headaches,fatigue,sleepdisturbances,irritability,a...
(Date:11/25/2009).../PRNewswire/-SentinelleMedicalInc.,aleadingmanufac...reandCalgaryScientificInc.,aleadingproviderofsoftw...fAegis(TM)Breast4DAdvancedVisualizationsoftware. ,...otprintWebclientbasedmedicalimagingofferinginthema...orzero-footprintaccess-requiringnosoftwaredownload...
(Date:11/25/2009)...PRNewswire-USNewswire/--AnarticlebyJanetWoodcock,M...search,titled"ADifficultBalance-PainManagement,Dru...heNewEnglandJournalofMedicine. ,, (Logo: http:/..., Inthearticle,WoodcockdiscussesFDAeffortstostr...oneeditandmanagingtherisksposedbyvariousanalgesics...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...Press, an advanced, online edition of the journal ...y may cause susceptibility// to herpes simplex vir...t scientific theory of how genes function in vulne...o French children with a deficiency for UNC-93B, a...
... failure patient management, mainly before heart t... Heart and Lung Transplantation (ISHLT) has been p... Heart and Lung Transplantation. These complete an...ere state in which the heart fails to pump suffici...
...nswick today announced an innovatory treatment for...eria// that attacks the gum but also supports heal... teeth. Severe form of periodontal disease aff...ment was presented at the 232nd National Meeting o...
...ans are not aware of the fact that drinking alcoho...lvation Army survey, binge drinking was "worryingl...f the 14 to 17-year-olds and 41 % of the18 to 24-y...nd they need to," Salvation Army spokesman Major M...
...ng in children of Mt Isa today to determine the le...ssions from Xstrata's two Mount Isa smelters.// ...ency raised concerns about the need for health che..., "The testing is precautionary because of Mount I...
...REG1A and EXTL3 in the patients with colorectal tu...a new study from the Max Delbrueck Center in Berli...on was also significantly higher in surgical biops...ually help in making decisions about management of...
Other Medicine News:Health News:Genetic susceptibility in viral encephalitis 2Health News:New guidelines for global heart patient management 2Health News:New guidelines for global heart patient management 3Health News:Plastic pill – a new treatment for periodontal disease 2Health News:The need for cancer warnings on alcohol packaging 2Health News:REG1A and its receptor EXTL3 signal the recurrence of colorectal cancer 2
(Date:11/25/2009)...ORDOVA,Calif.,Nov.25/PRNewswire/--AMPACFineChemica...(Nasdaq: APFC )announcedtodaythatitreceivedtheEnvi...AnnualStatewideEnvironmentalSummit,sponsoredbytheC...A),theIndustrialEnvironmentalAssociation(IEA)andth...nDiego.Thisisthemostprestigiousawardavailablefroma...
(Date:11/25/2009)...,Nov.25/PRNewswire/--Reportlinker.comannouncesthat... ,, UnitedStatesDentalDevicesMarketAnalysisand...m/p0158733/United-States-Dental-Devices-Market-Ana...esDentalDevicesMarketAnalysisandForecaststo2015 ,...orin-depthinformationanddatarelatingtotheUSdentald...
(Date:11/25/2009)...NSWICK,N.J.,Nov.25/PRNewswire/--SwissrayInternatio...aphy( ddR )systems,announcedtodaythatitsoperations...rmviewtowardsgrowingSwissray,smedicalimagingbrand....erty,aswellascontractsandinventory.After25yearsofs...eveloftechnologicaladvancementswithstableandsteady...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Swissray International Announces New Ownership 2Infectious Disease News and Infectious Diseases in Children Provide Online Reports Dedicated to Influenza A 28H1N1 29 virus 3A 57444 1Infectious Disease News and Infectious Diseases in Children Provide Online Reports Dedicated to Influenza A 28H1N1 29 virus 3A 57444 2Infectious Disease News and Infectious Diseases in Children Provide Online Reports Dedicated to Influenza A 28H1N1 29 virus 3A 57444 3Teamsters Oppose Baucus Plan to Tax Health Insurance Companies 57442 1Teamsters Oppose Baucus Plan to Tax Health Insurance Companies 57442 2Childrens Hospital of Wisconsin Launches H1N1 Prevention Campaign Geared Toward Children 57440 1Childrens Hospital of Wisconsin Launches H1N1 Prevention Campaign Geared Toward Children 57440 2Childrens Hospital of Wisconsin Launches H1N1 Prevention Campaign Geared Toward Children 57440 3
...harmaceutical,Inc. ("DOV", or the "Company") (OTCB...l Phase Ib results for DOV 21,947, its lead triple...depression and obesity. A,preliminary analysis of ...,safe and well-tolerated at the doses examined, an...n plasma triglyceride levels, as described more,fu...
...e-year follow-up overall,survival data from the X-...show that oral chemotherapy Xeloda(R) (capecitabin...nt - intravenous bolus 5-FU/LV (5-fluorouracil/,le...colon cancer. These,data were presented today at t...lona, Spain. Results show five-year overall survi...
Other Medicine Technology:DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study 2DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study 3DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study 4DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study 5Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting 2Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting 3Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting 4
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: